January 2, 2024 (press release) –
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
About
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com .
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-42nd-annual-jp-morgan-healthcare-conference-302024454.html
SOURCE
Media, Kimbrel Arculeo, 336-436-8263, Media@Labcorp.com, Investor Relations, Christin O'Donnell, 336-436-5076, Investor@Labcorp.com
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.